SJ5-16021-82848 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-10-07
Dose 1 — Moderna
2022-10-22
Registered in v-safe
2022-10-22
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-10-30
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-11-04
Survey response — day 28, dose 1, under 3
MedDRA: Viral infection — Feeling: Poor

Free text: Viral infection

MedDRA releases: 2024-11 · check-in free text available
2022-11-11
Survey response — day 35, dose 1, under 3
MedDRA: Viral infection — Feeling: Fair

Free text: Continued viral infection

MedDRA releases: 2024-11 · check-in free text available
2022-11-18
Dose 2 — Moderna
2022-11-20
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-11-21
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-11-25
Survey response — day 7, dose 2, under 3
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-12-02
Survey response — day 14, dose 2, under 3
MedDRA: COVID-19 — Feeling: Fair

Free text: COVID infection

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-16
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-23
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-30
Survey response — day 42, dose 2, under 3
MedDRA: Body height decreased — Feeling: Good

Free text: Significant drop on height growth chart at routine checkup from 6 to 9 months.

MedDRA releases: 2024-11 · check-in free text available
2023-02-17
Survey response — 3 months, dose 2, under 3
MedDRA: Respiratory tract infection — Feeling: Good

MedDRA releases: 2024-11
2023-05-21
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-10-07	Moderna	No
2	2022-11-18	Moderna	No

Free text

Release 12 (Under 3) — day 28, dose 1, under 3

2022-11-04

Symptoms: Viral infection

Release 12 (Under 3) — day 35, dose 1, under 3

2022-11-11

Symptoms: Continued viral infection

Release 12 (Under 3) — day 7, dose 2, under 3

2022-11-25

Systemic reaction (other): No

Release 12 (Under 3) — day 14, dose 2, under 3

2022-12-02

Symptoms: COVID infection

Release 12 (Under 3) — day 42, dose 2, under 3

2022-12-30

Symptoms: Significant drop on height growth chart at routine checkup from 6 to 9 months.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Body height decreased	·	·	✓
SD	COVID-19	·	·	✓
SD	Respiratory tract infection	·	·	✓
SD	Viral infection	·	·	✓
SRO	No adverse event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release